FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Get Involved

Your support powers research breakthroughs, access to care, and community connections that matter.

Thank you for submitting the partner form. We look forward to discussing partnership opportunities.